SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-351750
Filing Date
2012-08-13
Accepted
2012-08-13 12:56:46
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d354939d10q.htm 10-Q 294337
2 EX-10.2 d354939dex102.htm EX-10.2 35906
3 EX-10.3 d354939dex103.htm EX-10.3 6468
4 EX-31.1 d354939dex311.htm EX-31.1 6794
5 EX-31.2 d354939dex312.htm EX-31.2 6802
6 EX-32.1 d354939dex321.htm EX-32.1 5256
  Complete submission text file 0001193125-12-351750.txt   1989355

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT oxgn-20120630.xml EX-101.INS 208517
8 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20120630.xsd EX-101.SCH 20364
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20120630_cal.xml EX-101.CAL 26754
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20120630_def.xml EX-101.DEF 33188
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20120630_lab.xml EX-101.LAB 170044
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20120630_pre.xml EX-101.PRE 115963
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 121026794
SIC: 2836 Biological Products, (No Diagnostic Substances)